Your stem cells are your body’s natural healing cells. They are recruited by chemical signals emitted by damaged tissues to repair and regenerate your damaged cells. Stem cells derived from your own tissues may well be the next major advance in medicine. Stem Cell Life at Clinic 42 has the technology to produce a solution rich with your own stem cells. Under audited protocols these can be deployed to treat a number of degenerative conditions and diseases.
Stem cells can be either adult or embryonic. Adult stem cells can be derived from bone marrow or fat and can be the patient’s own or from someone else. We use only the patient’s own (or autologous), adult (non-embryonic), fat derived mesenchymal stem cells . There have been no cases reported of adult mesenchymal stem cells contributing to tumour formation. Using the patient’s own cells prevents any risk of risk of rejection. For clinical data, please read this article.
You may be considering stem cell therapy for a particular condition or your physician may be treating you for a condition that he/she feels might respond to stem cells therapy. At your initial consultation, you will see our doctor who has expertise in stem cell therapy to determine whether stem cell therapy might be appropriate for you. Your decision to proceed with treatments will need to be made between you and your doctor. Patients who have active infections or cancer are not candidates for stem cell treatments.
If you think you may be a candidate for one of our stem cell deployment protocols, you may apply for a consultation online using our candidate application form or contact us on (09) 638 4242.
Stem cells can be either adult or embryonic. We use only adult (non-embryonic) stem cells. There have been no cases reported of adult mesenchymal stem cells contributing to tumour formation.
Stem Cell Life specialises in the use of fat derived stem cells. With our current technology, we can harvest your own fat cells under local anaesthetic, break down the collagen that binds the fat and stem cells and then separate out a solution rich in your own stem cells. The process used by Stem Cell Life yields extremely high numbers of stem cells. Fat can be harvested from any area on your body that has an adequate fat supply, but we prefer to harvest it from the areas that will give you the best yield of cells. The mini-liposuction, done under local anaesthesia, takes about half an hour. This procedure is done under strict sterility and the processing of the cells is done under a completely closed system that is not even exposed to air. Viable cells are then counted for your record. One of our experts from our multidisciplinary staff will inject the cells according to the most appropriate route. This is called “deployment”.
Because it’s your own DNA material, there can be no rejection. A solution rich with your tiny stem cells are administered through injection into tissues, joints, arteries or veins. The entire process takes about three hours.
Stem cells are tiny “progenitor” cells. They have the potential to recognise tissue injury and repair injured cells. In the right environment, these stem cells can change (differentiate) into bone, cartilage, muscle, fat, collagen, neural tissue, blood vessels and even some organs. Stem cells may also affect healing by secreting special chemical messengers that repair damaged tissue. Adult stem cells appear to be particularly effective in improving painful joints, repairing cartilage and ligaments and even painful conditions along the spine. There are many clinical trials with stem cells going on right now. In one example, patients suffering from heart attacks have been given their own fat derived stem cells so they could speed up repair of the heart muscle and indeed, these patients have shown quicker healing compared to those not given real stem cells. Such studies have encouraged the use of stem cell deployments for ischemic and idiopathic cardiomyopathy. There have been reports of improvements with MS, Muscular Dystrophy, Parkinson’s, ALS and Stroke. Stem cells may be effective in the treatment of Macular Degeneration, Crohn’s disease and numerous pulmonary conditions such as COPD, asthma and fibrosis. Stem cells are now used for patients with kidney failure and in the treatment of critical limb ischemia. There are many common conditions that may benefit from stem cell therapy. At Clinic 42 we may not able to offer treatments for all of the above-mentioned conditions and assess each case on its merits as to suitability for treatment.
The following trials represent some of the more exciting research currently being undertaken in the exciting field. Please remember, these studies aren’t published and no therapeutic claims or outcomes can be made. Regenerative Medicine is the future and is being led by Stem Cell research.
- Intravenous Stem Cells After Ischemic Stroke
- Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis
- Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus
- Stem Cells and Treatment of ALS
- Stem Cells and Treatment of ALS (2)
- Evaluation of Stem Cell Therapy in Treatment of Multiple Sclerosis (MS)
- Stem Cell Therapy and Secondary Progressive MS
- Stem Cells in Rapidly Evolving Active MS
Treatment with Stem Cell Therapy has been shown to reduce infarct size and improve functional outcome. This clinical data shows the promise of this exciting treatment option for Stroke patients.
Regeneration of meniscus cartilage with Stem Cells has shown remarkable results. Clinical data suggests the treatment of knee injury with Stem Cell Therapy could yield an increase in meniscal cartilage volume and provide an effective treatment for knee injury.
MSCs (including Adipose Derived Stem Cells) have several valuable functions that make them a promising therapeutic option in the field of regenerative medicine, including the secretion of anti-inflammatory cytokines and growth factors, the migration of cells to the site of injury when administered and the ability to ‘rescue’ cells through the transfer of functional mitochondria. They also offer the possibility of autologous cell transplantation, circumventing immune rejection. These properties, among others, make MSCs a promising potential therapeutic agent in the treatment of chronic lung diseases. Read more.
The ability to repair tissue via Stem Cell therapy may allow management a wide variety of diseases including peripheral joint injuries and osteoarthritis. This review highlights the developments in cellular medicine that may soon permit physicians to treat a much wider variety of clinical conditions using Stem Cell Therapy.